Medical Biopreservation Equipment Market Overview (2025–2034)
Luton, Bedfordshire, United Kingdom, May 15, 2025 (GLOBE NEWSWIRE) — The global medical biopreservation equipment market is valued at approximately $3.8 billion in 2024, with projections indicating significant growth, anticipating a market value of around $6.2 billion by 2034. This trajectory represents a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period of 2025 to 2034.
The Medical Biopreservation Equipment Market is an essential segment of the healthcare landscape, dedicated to the preservation of vital biological materials such as cells, tissues, and organs. As global healthcare systems continue to evolve, the demand for advanced biopreservation solutions is becoming increasingly critical. This market includes a broad array of technologies—ranging from ultra-low temperature freezers and cryopreservation systems to temperature-controlled storage units—that ensure the viability of biological specimens for extended periods.
This remarkable growth is fueled by the rising need for organ transplants, increasing biobanking activities, and significant progress in regenerative medicine.
Positive Market Outlook Driven by Healthcare Investment and R&D
The future of the medical biopreservation equipment market looks promising, backed by growing investments in healthcare infrastructure and biopharmaceutical research. Key drivers include:
Increasing chronic disease prevalence
Aging global population
Surging interest in regenerative medicine
Government support for R&D initiatives
For instance, the National Science Foundation has been funding innovative projects aimed at improving biopreservation techniques, reinforcing the sector’s strategic role in healthcare advancement.
Cryopreservation: A Key Growth Driver
Cryopreservation—the process of storing biological samples at ultra-low temperatures to halt all metabolic activity—has emerged as a cornerstone of the biopreservation market. It plays a vital role in:
Fertility preservation
Stem cell therapy
Biobanking
Regenerative medicine
The cryopreservation segment is expected to experience robust growth due to the increasing number of fertility clinics and ongoing advancements in cell-based therapies.
Leading companies shaping the medical biopreservation equipment landscape include:
Thermo Fisher Scientific
BioLife Solutions
Panasonic
Azenta
Biomatrica
MVE Biological Solutions
Sigma-Aldrich
X-Therma
STEMCELL Technologies
Taylor-Wharton
So-Low
PrincetonCryo
Custom Biogenic Systems
LifeLine Scientific
This report is also available in the following languages : Japanese (医療生体保存装置市場), Korean (의료 생물 보존 장비 시장), Chinese (医用生物保存设备市场), French (Marché des équipements de bioconservation médicale), German (Markt für medizinische Biokonservierungsgeräte), and Italian (Mercato delle attrezzature mediche di bioconservazione), etc.
The global cartilage regenerative device market is projected to reach an estimated value of $4.5 billion in 2024, with expectations to expand significantly over the forecast period from 2025 to 2034. The market is anticipated to achieve a compound annual growth rate (CAGR) of approximately 9.2%, driven primarily by advancements in biotechnology and an increasing prevalence of orthopedic disorders.
The global fiberoptic phototherapy device market is valued at approximately $550 million in 2024 and is projected to reach around $1.2 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 8.1% during the forecast period from 2025 to 2034.
The global pharmaceutical dissolution testing tools market is anticipated to reach approximately $1.1 billion in 2024, driven by increasing R&D activities and stringent regulatory requirements for drug development. The market is projected to grow significantly, with an estimated compound annual growth rate (CAGR) of around 7.5% from 2025 to 2034, leading to a projected market value of about $2.1 billion by 2034.
The global chronic wound care dressing market is projected to reach a value of approximately USD 12.3 billion in 2024, with a robust growth trajectory expected over the next decade. By 2034, the market is estimated to surpass USD 20 billion, reflecting a Compound Annual Growth Rate (CAGR) of around 5.5% during the forecast period from 2025 to 2034.
The global radiation dermatitis medicines market is valued at approximately $1.5 billion in 2024, with expectations to reach around $3 billion by 2034, driven by increasing cancer incidences and the rising adoption of radiotherapy. The market is projected to witness a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period from 2025 to 2034.
The global surgical intubation market is projected to reach approximately $7.5 billion in 2024, driven by advancements in medical technology and increasing demand for surgical procedures. Over the forecast period from 2025 to 2034, the market is expected to witness significant growth, with an estimated compound annual growth rate (CAGR) of 5.8%, propelling the market value to around $12 billion.
The global veterinary MRI scanning equipment market is valued at approximately $500 million. The market is projected to expand significantly, reaching an estimated $1.1 billion by 2034. This growth represents a Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period from 2025 to 2034.
The global market for serine proteases is projected to reach approximately $3 billion in 2024, driven by increasing applications in drug development and diagnostics, particularly within oncology and inflammatory diseases. Over the forecast period from 2025 to 2034, the market is expected to expand significantly, with a projected CAGR of around 6.5%, reflecting a robust growth trajectory fueled by advancements in biotechnology and personalized medicine.
The global blood group typing market is projected to be valued at approximately $4.2 billion in 2024, driven by increasing healthcare demands and advancements in diagnostic technologies. The market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 7.5% from 2025 to 2034, reaching an estimated value of $8.2 billion by the end of this forecast period.
The global casting and splinting equipment market is poised to reach an estimated value of approximately $2.6 billion in 2024. The market is projected to experience significant growth, with an expected value of around $4.5 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period from 2025 to 2034.
The global platelet incubator agitator market is valued at approximately $120 million in 2024, with expectations to reach around $200 million by 2034. This growth reflects a robust Compound Annual Growth Rate (CAGR) of approximately 6.5% during the forecast period from 2025 to 2034.
The global market for portable blood bag tube sealers is valued at approximately $120 million in 2024, driven by increasing demand for blood transfusions and enhanced safety measures in healthcare facilities. It is projected to reach around $220 million by 2034, reflecting a robust growth trajectory fueled by advancements in medical technologies and growing awareness of blood safety standards.
The global cyclotron system market for PET (Positron Emission Tomography) is valued at approximately $450 million in 2024, with expectations to reach around $850 million by 2034. This represents a robust Compound Annual Growth Rate (CAGR) of about 6.7% during the forecast period from 2025 to 2034.
The global angiographic contrast media market is valued at approximately $2.5 billion, driven by increasing diagnostic imaging procedures and advancements in radiology technology. The market is projected to grow at a compound annual growth rate (CAGR) of 5.8%, reaching around $4.2 billion by 2034.
The global market for non-ionic contrast agents is valued at approximately $3.2 billion in 2024, driven by increasing diagnostic imaging procedures and a growing preference for safer imaging modalities. The market is projected to reach nearly $5.1 billion by 2034, reflecting a robust compound annual growth rate (CAGR) of 4.6% during the forecast period from 2025 to 2034.
The global next-generation medical ultrasound system market is valued at approximately $6.5 billion in 2024, with expectations to reach around $10.2 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period of 2025–2034.
The global biomedical engineering materials market is valued at approximately $82 billion in 2024, with expectations to reach about $130 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of around 5.1% during the forecast period from 2025 to 2034.
Neuroscience Antibodies and Assays Technology Market
The global neuroscience antibodies and assays market is poised to reach an estimated value of $3.5 billion in 2024, with strong growth projected throughout the forecast period from 2025 to 2034. The market is anticipated to expand to approximately $6.75 billion by 2034, reflecting a robust Compound Annual Growth Rate (CAGR) of about 7.1%.
Medical Radiation Detection and Monitoring Solution Market
The global medical radiation detection and monitoring market is expected to reach approximately $5.7 billion in 2024, with a robust projected growth trajectory leading to an estimated market value of $9.8 billion by 2034. This represents a Compound Annual Growth Rate (CAGR) of around 5.5% during the forecast period of 2025–2034.
The global medical acid reducer market is valued at approximately $45 billion, reflecting steady growth driven by an increase in gastrointestinal disorders, evolving healthcare access, and a surge in self-medication trends. The market is projected to reach $62 billion by 2034, indicating significant opportunities, particularly in emerging markets where healthcare infrastructure is improving.
EU Venture Capital is a premier platform providing in-depth insights, funding opportunities, and market analysis for the European startup ecosystem. Wholly owned by EU Startup News, it connects entrepreneurs, investors, and industry professionals with the latest trends, expert resources, and exclusive reports in venture capital.
